Purpose
|
Developed by Schering-Plough after its merger with Organon International, asenapine is a sublingually administered, atypical antipsychotic for treatment of schizophrenia and acute mania associated with bipolar disorder. Asenapine also belongs to the dibenzo-oxepino pyrrole class. It is also for severe post-traumatic stress disorder nightmares in soldiers as an off-label use. FDA approved on August 13, 2009.
|
Characteristics
|
Tradename: Org 5222 maleate Target: 5-HT receptor antagonist,Adrenergic Receptor antagonist Receptor: 5-HT Receptor,Adrenergic receptor ,Dopamine receptor,Histamine recepto
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
99?% +
|
Formula
|
C21H20ClNO5
|
Solubility
|
Soluble in DMSO
|